We are delighted to welcome Dr Dariusz Hareza to the touchINFECTIOUS DISEASES Editorial Board. Dr Hareza is an Assistant Professor of Medicine (Infectious Diseases) at Northwestern University Feinberg School of Medicine, Chicago, IL, USA. He brings to the board a growing reputation in clinical epidemiology and antimicrobial resistance, with particular expertise in comparative effectiveness and […]
A double-stranded DNA virus of the Orthopoxvirus family, mpox (formerly monkeypox), continues to infect people daily, following the 2022 global outbreak.1 Two clades (clade 1 and clade 2) have been identified, with the 2022 outbreak caused by a subclade of clade 2, referred to as clade 2b.2 Comparatively, clade 1 leads to a more severe disease state and greater […]
The US Food and Drug Administration (FDA) has expanded the indication of the pangenotypic direct-acting antiviral (DAA) combination, glecaprevir/pibrentasvir (Mavyret®; AbbVie Inc., North Chicago, IL, USA), to include the treatment of acute hepatitis C virus (HCV) infection in adults and children aged ≥3 years, with or without compensated cirrhosis. This decision makes it the first […]
Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.
Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.
In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.
A double-stranded DNA virus of the Orthopoxvirus family, mpox (formerly monkeypox), continues to infect people daily, following the 2022 global outbreak.1 Two clades (clade 1 and clade 2) have been identified, with the 2022 outbreak caused by a subclade of clade 2, referred to as ...
Welcome to the latest edition of touchREVIEWS in Infectious Diseases, where we continue our mission to deliver insightful, cutting-edge perspectives in infectious disease diagnosis and management. This issue offers an array of topics spanning diagnostics, service delivery innovations and preventive ...
Sponsored content from GSK. Watch leading experts Jeremy Szeto and Kristen Robillard discuss their personal experience with adult immunization programs and the approaches they use in their practices to help optimize adult immunization rates.
Share your knowledge, influence clinical practices and enhance patient care in Infectious Diseases today!
In this episode, we explore how point-of-care testing is transforming the management of sexually transmitted infections (STIs). Joined by Dr Libby van Gerwen, we discuss the rising global STI rates and the role these innovative tests play in addressing the issue. We also explore the challenges current point-of-care tests face and how next-generation advancements could further transform the future of STI diagnosis and treatment.
Highlights Determining infection and multidrug resistance (MDR) rates continuously helps to detect the problem to be solved, including outbreaks. Cleaning and disinfection play an important role in preventing MDR and evaluating and correcting the process for better results. MDR control ...
Two experts discuss best practices for antiretroviral therapy (ART) selection for people living with HIV.
Watch three experts describe the HIV life cycle, the rationale for ART and how to manage ART resistance.
The expansion of HIV treatment access during the past two decades, particularly in low- and middle-income countries, stands as a significant accomplishment in the field of public health.1Â Currently, there are an estimated 30 million people on antiretroviral treatment for HIV ...
Respiratory syncytial virus (RSV) is often of increased concern in the autumn and winter months, especially for women who are pregnant, or those with newborns.1Â Worldwide, RSV is the second leading cause of death (second to malaria) in children during ...
Vaginal symptoms are one of the most common reasons for women accessing acute healthcare in the USA.1Â Vaginitis is most commonly evaluated based on clinical observations, including assessment of discharge characteristics, vaginal pH and, in some settings, microscopic examination of ...
We are excited to introduce the latest edition of touchREVIEWS in Infectious Diseases. Our mission is to bring you thought-provoking interviews, reviews, editorials, case studies and original research within the realm of infectious diseases. We aspire to engage infectious disease ...
The treatment of people with HIV (PWH)/hepatitis B virus (HBV) co-infection, especially those who have additional comorbidities requiring multiple drug therapies can be problematic. Bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) is a co-formulated medication consisting of two components ...
By sharing, listening and gaining an understanding of the real-life experiences of individuals living with a condition, clinicians and patients can better work together to improve care and outcomes and shape the healthcare system and policy of the future. Patient ...
Despite being the most severe form of viral hepatitis, there is no FDA-approved therapy for chronic hepatitis delta (CHD).1 Patients with CHD can progress to cirrhosis, as early as 5–10 years after infection. Further complications can also develop, such as esophageal ...
Article highlights Erythrasma is a common chronic superficial cutaneous bacterial infection caused by Corynebacterium minutissimum when conditions are conducive. Corynebacterium minutissimum produces coproporphyrin III (a phosphor) that emits a coral pink fluorescence under Wood’s lamp and helps confirm the ...
Introducing the Editorial Board of touchREVIEWS in Infectious Diseases, who support our mission to advance medical knowledge and practice by ensuring the integrity, relevance, and impact of the content we publish. Together, we strive to foster a vibrant academic community and contribute to the continuous improvement of healthcare worldwide.
HIV and Policy
Infectious Diseases Physician, General Practitioner, Ministry of Health of Zambia, Africa
Case Management Specialist, Zambia National Public Health Institute, Zambia, Africa
Dr Nyuma Mbewe is a specialist in Internal Medicine and Infectious Diseases (Mmed-ID)
Antimicrobial Resistance
Assistant Professor of Medicine (Infectious Diseases), Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Dr Dariusz Hareza is Assistant Professor of Medicine (Infectious Diseases) at the Northwestern University Feinberg School of Medicine, Chicago, IL, USA. He is working with mentors to research antimicrobial resistance (AMR). He is also a fellow at the NIH-funded Antibacterial Resistance Leadership Group (ARLG) and recently finished an infectious diseases fellowship at Johns Hopkins University, Baltimore, MD, USA, where he received a master’s degree in clinical investigation. His research involves the molecular epidemiology and clinical outcomes in extended-spectrum beta-lactamase producing Enterobacterales and difficult-to-treat Pseudomonas aeruginosa.
HIV
Assistant Professor, Division of Infectious Diseases, Rutgers New Jersey Medical School, Newark, NJ, USA
Amesika Nyaku, MD MS is an Assistant Professor in the Division of Infectious Diseases at Rutgers New Jersey Medical School and a physician-scientist. She provides clinical care for people living with HIV or other infectious diseases and substance use disorders. Her research interests lie at the intersection of HIV and substance use disorders. She focuses on 1) evaluating long-acting therapeutics for HIV and opioid use disorder, 2) the implementation of integrated care models for HIV and substance use disorders to improve health outcomes, and 3) increasing the inclusion and participation of racial/ethnic minorities in clinical trials research. She is also co-director of the Northern New Jersey Medication-Assisted Treatment Center of Excellence that is tasked with assisting the state in expanding access to medication-assisted treatment for opioid use disorder through education, novel service delivery and community collaboration.
Fungal & Respiratory Infections
Postdoctoral Researcher and Project Manager, University Hospital of Cologne, Cologne, Germany
Dr. Jon Salmanton-GarcÃa is a researcher specializing in infectious diseases in immunocompromised patients, with a particular focus on respiratory viral infections in hematology and fungal diseases. He holds a PhD in Health Sciences from the University of Cologne and has published numerous scientific articles while presenting his work at national and international congresses. He serves as the scientific coordinator of the EPICOVIDEHA registry, which investigates respiratory viral infections in hematological patients, and leads the Diagnostic and Treatment Capacity of Invasive Fungal Infections initiative. Additionally, he has held leadership roles in European medical associations, contributing to advances in infection management for vulnerable populations.
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.
Or use a Social Account.
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.